-
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Accolade, Inc. (ACCD)
-
Truist Securities Reiterates Buy Rating on Accolade Inc. (ACCD)
-
Accolade (ACCD) to Resume Trading at 9 am
-
Transcarent To Acquire Accolade (ACCD) for $7.03 per share
-
Accolade (ACCD) Halted, News Pending
-
Accolade Inc. (ACCD) PT Lowered to $6 at Wells Fargo, 'Building Conviction Challenging Amid Uncertainty'
-
Accolade Inc. (ACCD) PT Lowered to $8 at Stephens
-
Accolade Inc. (ACCD) PT Lowered to $7 at Canaccord Genuity
-
Accolade Inc. (ACCD) PT Lowered to $7.50 at Truist Securities
-
Accolade Inc. (ACCD) PT Lowered to $5.75 at BofA Securities
-
Piper Sandler Reiterates Overweight Rating on Accolade Inc. (ACCD)
-
Truist Securities Reiterates Buy Rating on Accolade Inc. (ACCD)
-
Truist Securities Reiterates Buy Rating on Accolade Inc. (ACCD)
-
BTIG Reiterates Neutral Rating on Accolade Inc. (ACCD)
-
Barclays Reiterates Equalweight Rating on Accolade Inc. (ACCD)
-
Accolade (ACCD) Tops Q2 EPS by 14c; reiterates guidance
-
Truist Securities Reiterates Buy Rating on Accolade Inc. (ACCD)
-
Needham Reiterates Buy Rating on Accolade Inc. (ACCD)
-
Accolade (ACCD) Trades Higher on Market Chatter
-
Midday movers: Nike and Accolade fall; Humana and Infinera rise
-
Accolade Inc. (ACCD) PT Lowered to $8 at Stifel
-
Accolade Inc. (ACCD) PT Lowered to $13 at Canaccord Genuity
-
Accolade Inc. (ACCD) PT Lowered to $8 at Needham
-
Accolade Inc. (ACCD) PT Lowered to $9 at Truist Securities
-
Accolade Inc. (ACCD) PT Lowered to $5 at DA Davidson
-
After-hours movers: Nike, Infinera, Accolade and more
-
Accolade (ACCD) Tops Q1 EPS by 13c, Offers Guidance

